| Breast cancer therapy affects the expression of antineonatal Nav1. 5 antibodies in the serum of patients with breast cancer H Rajaratinam, NS Rasudin, TAD Al Astani, NF Mokhtar, MM Yahya, ... Oncology Letters 21 (2), 108, 2021 | 11 | 2021 |
| Andrographolide is an alternative treatment to overcome resistance in er-positive breast cancer via cholesterol biosynthesis pathway H Rajaratinam, SNM Nafi The Malaysian Journal of Medical Sciences: MJMS 26 (5), 6, 2019 | 9 | 2019 |
| Passage number of 4T1 cells influences the development of tumour and the progression of metastasis in 4T1 orthotopic mice H Rajaratinam, NS Rasudin, S Safuan, NA Abdullah, NF Mokhtar, ... The Malaysian Journal of Medical Sciences: MJMS 29 (3), 30, 2022 | 8 | 2022 |
| Discovering the triad between Nav1. 5, breast cancer, and the immune system: A fundamental review and future perspectives H Rajaratinam, NF Mokhtar, N Asma-Abdullah, WEM Fuad Biomolecules 12 (2), 310, 2022 | 7 | 2022 |
| Chitosan from Marine Biowaste: Current and Future Applications in Tissue Engineering NH Syed, H Rajaratinam, AA Nurul Sustainable Material for Biomedical Engineering Application, 87-106, 2023 | 2 | 2023 |
| The phytochemical compound of Kelantan grown Annona muricata leaves and its anti-proliferative properties on MCF 7 breast cancer cells N Ismail, H Rajaratinam, KC Ghazali, SFM Salleh, W Wan Ibrahim, ... Sains Malaysiana, 2023 | 1 | 2023 |
| Extracellular Vesicles: A Potent Therapeutic Tool for Cartilage Regeneration NH Syed, M Azlan, MR Ahmad Mohd Zain, H Rajaratinam, NA Mohd Noor, ... Cartilage: From Biology to Biofabrication, 405-423, 2023 | | 2023 |
| The roles of circulating neonatal nav1. 5 (NNAV1. 5) and its antibodies in cancer progression of 4T1 orthotopic mice model and breast cancer patients HA Rajaratinam | | 2023 |
| Investigation on Circulating Neonatal Nav1. 5 (nNav1. 5) and Its Antibodies in the Blood and Serum of 4T1 Orthotopic Mice Model and Breast Cancer Patients from Hospital … H Rajaratinam, NS Rasudin, MM Yahya, WZW Zain, S Safuan, ... Asian Journal of Medicine and Biomedicine 6 (S1), 55-58, 2022 | | 2022 |
| Circulating Neonatal Nav1. 5 (nNav1. 5) Antigen and Anti-nNav1. 5 Antibodies as Potential Biomarkers for Breast Cancer Metastasis H Rajaratinam, NS Rasudin, MM Yahya, WANZ WAN Sains Malaysiana 51 (9), 2967-2984, 2022 | | 2022 |
| Diserahkan: 4 Januari 2022/Diterima: 14 Mac 2022 H RAJARATINAM, NURS RASUDIN, MM YAHYA, WANZWAN ZAIN, ... Sains Malaysiana 51 (9), 2967-2984, 2022 | | 2022 |
| Received: 4 January 2022/Accepted: 14 March 2022 H RAJARATINAM, NURS RASUDIN, MM YAHYA, WANZWAN ZAIN, ... Sains Malaysiana 51 (9), 2967-2984, 2022 | | 2022 |
| The Prevalence of SNP rs12517451 in Gene Transcribing Dihydrofolate Reductase and Drug Adverse Effects among MTXtreated Rheumatoid Arthritis Patients in Kelantan, Malaysia. MS Zahari, H Rajaratinam, NS Bakar Malaysian Journal of Medicine & Health Sciences, 2021 | | 2021 |
| Uncovering the Immunogenicity of Neonatal Nav1. 5 by Utilising Serum Samples from 4T1 Orthotopic Mice and Breast Cancer Patients H Rajaratinam | | |
